Stocks and Investing
Stocks and Investing
Thu, July 13, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, July 12, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, July 11, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Biren Amin Initiated (VRTX) at Strong Buy and Held Target at $155 on, Jul 11th, 2017
Biren Amin of Jefferies, Initiated "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy and Held Target at $155 on, Jul 11th, 2017.
Biren has made no other calls on VRTX in the last 4 months.
There are 4 other peers that have a rating on VRTX. Out of the 4 peers that are also analyzing VRTX, 0 agree with Biren's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Biren
- Alan Carr of "Needham" Upgraded from Hold to Strong Buy on, Friday, June 23rd, 2017
- Hartaj Singh of "Oppenheimer" Upgraded from Hold to Buy on, Friday, June 2nd, 2017
- Do Kim of "BMO Capital" Upgraded from Hold to Buy on, Wednesday, March 29th, 2017
- Liisa Bayko of "JMP Securities" Upgraded from Hold to Buy on, Friday, March 17th, 2017
Contributing Sources